99 related articles for article (PubMed ID: 17056111)
1. HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression.
Syampurnawati M; Tatsumi E; Furuta K; Takenokuchi M; Nakamachi Y; Kawano S; Kumagai S; Saigo K; Matsui T; Takahashi T; Nagai K; Yabe H; Kondo S; Hayashi Y
Leuk Res; 2007 Jul; 31(7):921-9. PubMed ID: 17056111
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q
Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790
[TBL] [Abstract][Full Text] [Related]
3. DR negativity is a distinctive feature of M1/M2 AML cases with NPM1 mutation.
Syampurnawati M; Tatsumi E; Ardianto B; Takenokuchi M; Nakamachi Y; Kawano S; Kumagai S; Saigo K; Matsui T; Takahashi T; Nagai K; Gunadi ; Nishio H; Yabe H; Kondo S; Hayashi Y
Leuk Res; 2008 Jul; 32(7):1141-3. PubMed ID: 18180033
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
6. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
[TBL] [Abstract][Full Text] [Related]
7. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
8. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
Sritana N; Auewarakul CU
Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemia.
Gagyi E; Horváth E; Bödör C; Timár B; Matolcsy A; Pávai Z
Rom J Morphol Embryol; 2006; 47(4):331-7. PubMed ID: 17392978
[TBL] [Abstract][Full Text] [Related]
10. Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia.
Bang SM; Ahn JY; Park J; Park SH; Park J; Cho EK; Shin DB; Lee JH; Yoo SJ; Jeon IS; Kim YK; Kim HJ; Kim HN; Lee IK; Kang HJ; Shin HY; Ahn HS
J Korean Med Sci; 2008 Oct; 23(5):833-7. PubMed ID: 18955790
[TBL] [Abstract][Full Text] [Related]
11. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
Mori Y; Yoshimoto G; Kumano T; Miyamoto T; Iino T; Takenaka K; Iwasaki H; Harada N; Kinukawa N; Nagafuji K; Teshima T; Shimoda K; Akashi K; Harada M
Eur J Haematol; 2007 Jul; 79(1):17-24. PubMed ID: 17598835
[TBL] [Abstract][Full Text] [Related]
12. The surface molecular signature of leukemic cells is associated with NPM1 mutations and FLT3 -ITD in patients with de novo acute myeloid leukemia.
Su L; Gao SJ; Li W; Tan YH; Cui JW; Han W
Acta Haematol; 2014; 131(3):148-52. PubMed ID: 24192815
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations.
Riccioni R; Pelosi E; Riti V; Castelli G; Lo-Coco F; Testa U
Br J Haematol; 2011 Apr; 153(1):33-42. PubMed ID: 21332708
[TBL] [Abstract][Full Text] [Related]
14. Correlation of FLT3 mutations with expression of CD7 in acute myeloid leukemia.
Baqai J; Crisan D
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):104-8. PubMed ID: 25679063
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
[TBL] [Abstract][Full Text] [Related]
16. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations.
Gajendra S; Gupta R; Thakral D; Gupta SK; Jain G; Bakhshi S; Sharma A; Sahoo RK; Kumar L; Rai S; Singh S; Upadhyay AD
Int J Lab Hematol; 2023 Apr; 45(2):221-228. PubMed ID: 36504282
[TBL] [Abstract][Full Text] [Related]
17. Reversal of FLT3 mutational status and sustained expression of NPM1 mutation in paired presentation, and relapse samples in a patient with acute myeloid leukemia.
Radojkovic M; Tosic N; Colovic N; Ristic S; Pavlovic S; Colovic M
Ann Clin Lab Sci; 2012; 42(2):186-90. PubMed ID: 22585616
[TBL] [Abstract][Full Text] [Related]
18. FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.
Li L; Piloto O; Kim KT; Ye Z; Nguyen HB; Yu X; Levis M; Cheng L; Small D
Br J Haematol; 2007 Apr; 137(1):64-75. PubMed ID: 17359372
[TBL] [Abstract][Full Text] [Related]
19. Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: implications for the biological properties of AML blasts.
Pekova S; Ivanek R; Dvorak M; Rueggeberg S; Leicht S; Li X; Franz T; Kozak T; Vrba J; Koza V; Karas M; Schwarz J; Cetkovsky P; Prucha M
Leuk Res; 2009 Oct; 33(10):1409-16. PubMed ID: 19181379
[TBL] [Abstract][Full Text] [Related]
20. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L
Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
